Abstract
In proliferative vitreoretinopathy (PVR), unwanted cellular growth may occur under or over the retina following retinal detachment surgery or penetrating injury to the eye, and this often leads to unsuccessful surgery.1 Meticulous membrane removal with the adjunctive use of silicone oil for prolonged tamponade has increased surgical success rates2,3; however, PVR may recur despite this surgical modality.4
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ryan SJ. The pathophysiology of proliferative vitreo-retinopathy in its management. Am J Ophthalmol 1985; 100:188–193.
Grey HB, Leaver PK. Silicone oil in the treatment of massive preretinal retraction. I. Results in 105 eyes. Br J Ophthalmol 1979; 63:355–360.
Gonvers M. Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1985; 100:239–245.
Glaser BM. Treatment of giant retinal tears combined with proliferative vitreoretinopathy. Ophthalmology 1986;93:1193–1197.
Litin BS, Jones MA, Kwong EM, Herschier J. Effect of antineoplastic drugs on cell proliferation-individually and in combination. Ophthalmic Surg 1985; 16:34–39.
Fiscella R, Elvart J, Peyman GA, Yue B. In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone. Ophthalmic Surg 1985; 16:247–249.
Blumenkrantz MS, Harter MK, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines. Arch Ophthalmol 1987; 105:396–399.
Stern WH, Lewis GP, Erickson PA, et al. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol 1983; 96:33–42.
DeVita VT, Denham C, Davidson JD, Oliverio VT. The physiological disposition of the carcinostatic l,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) in man and animals. Clin Pharm Ther 1967; 8:566–577.
Loo TL, Dion RL. Colorimetric method for the determination of l,3-bis(2-chloroethyl)-1-nitrosourea. J Pharm Sci 1965; 54:809–810.
Tresher RJ, Ehrenberg M, Machemer R. Gasmediated gas compression: an experimental alternative to mechanized vitrectomy. Graefes Arch Clin Exp Ophthalmol 1984; 221:192–198.
Lambrou FH, Burke JM, Arberg TM. Silicone oil enhances proliferation in experimental proliferative vitreo-retinopathy. Invest Ophthalmol Vis Sci 1987; 28(Suppl):290.
Miller DF, Bay JW, Lederman RJ, et al. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas. Ophthalmology 1985; 92:402–406.
Liu HS, Perry HD, Refojo MF. Tolerance of normal rabbit eyes to the antineoplastic carmustine. Ophthalmologica 1980; 181:41–46.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Tolentino, F.I., Cajita, V.N., Chung, H., Ueno, N., Refojo, M.F. (1988). Carmustine (BCNU) in Silicone Oil Prevents Proliferation of Cultured Cells. In: Freeman, H.M., Tolentino, F.I. (eds) Proliferative Vitreoretinopathy (PVR). Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3910-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3910-9_23
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8398-0
Online ISBN: 978-1-4612-3910-9
eBook Packages: Springer Book Archive